<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We developed a small animal embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> model for pharmacological screening trials </plain></SENT>
<SENT sid="1" pm="."><plain>Microspheres are injected into the carotid circulations and group <z:mpath ids='MPATH_110'>embolus</z:mpath> dose-response relationships are calculated </plain></SENT>
<SENT sid="2" pm="."><plain>Emboli quantity is related to neurologic injury, and small changes in neurologic function are detectable </plain></SENT>
<SENT sid="3" pm="."><plain>Rabbits tolerated twice as many microspheres when cyproheptadine-treated after embolization </plain></SENT>
<SENT sid="4" pm="."><plain>This demonstrated both the sensitivity of the model and the value of <z:chebi fb="0" ids="48279">serotonin antagonists</z:chebi> in reducing neurological injury </plain></SENT>
</text></document>